Tg Therapeutics (TGTX) Operating Leases (2019 - 2026)
Tg Therapeutics (TGTX) recorded Operating Leases of $7.14 million in Q2 2026, down 5.9% from $7.59 million a year earlier but up 8.3% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Tg Therapeutics reported Operating Leases of $7.02 million, down 13.7% from FY2024.
- Annual Operating Leases has declined for three straight years, with a five-year compound annual growth rate of -7.6% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $8.13 million in FY2024 (-11.9%), $9.23 million in FY2023 (-10.8%), $10.34 million in FY2022 (+5.0%) and $9.85 million in FY2021 (-5.4%).
- Quarterly Operating Leases has ranged from $6.6 million in Q1 2026 to $10.58 million in Q3 2022 over the past five years.
- On a year-over-year basis, Operating Leases has declined for 14 consecutive quarters, with an average decline of 12.2% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 5.6% in Q3 2022, against a decline of 16.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.6 million (Q1 2026), $7.02 million (Q4 2025) and $7.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Tg Therapeutics | 8.60 Bn | 7.99 Bn | 199.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.14 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 7.02 Mn |
| Sep 30, 2025 | 7.31 Mn |
| Jun 30, 2025 | 7.59 Mn |
| Mar 31, 2025 | 7.86 Mn |
| Dec 31, 2024 | 8.13 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 8.96 Mn |
| Dec 31, 2023 | 9.23 Mn |
| Sep 30, 2023 | 9.52 Mn |
| Jun 30, 2023 | 9.81 Mn |
| Mar 31, 2023 | 10.08 Mn |
| Dec 31, 2022 | 10.34 Mn |
| Sep 30, 2022 | 10.58 Mn |
| Jun 30, 2022 | 9.98 Mn |
| Mar 31, 2022 | 10.32 Mn |
| Dec 31, 2021 | 9.85 Mn |
| Sep 30, 2021 | 10.02 Mn |
API Access
Tg Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();